Manufacturing Daily Summary
Manufacturing Daily Summary: What Happened on October 20, 2026
Bayer plans $2.2 billion Ohio manufacturing campus
GSK’s $800 million Pennsylvania hub is expected to create more than 300 jobs over five years.
Today in brief
Bayer plans a $2.2 billion drug-manufacturing campus in New Albany, Ohio, with its first production lines targeted to start operating in 2031.1 The project is expected to support about 1,500 construction jobs and create about 600 permanent jobs.1
GSK plans an $800 million research and manufacturing hub in Pennsylvania, with more than 300 jobs expected over five years.2
Bayer targets 2031 for first Ohio production lines
Bayer plans to invest $2.2 billion in a New Albany, Ohio, campus initially focused on cancer, cardiovascular and kidney therapies.1 The modular site is designed to make drug substance, the active ingredient, and finished medicines.1
The first drug-substance production lines are targeted for 2031, followed by a product-manufacturing module in 2034.1 Bayer expects the project to create about 600 permanent jobs, while construction is expected to support about 1,500 jobs.1
Bayer said the investment is part of the $7 billion it allocated to U.S. research and development and manufacturing over the past five years.1 The company said the campus will expand its global supply network and improve its ability to serve markets reliably.1
Also published
- Building a Pragmatic E&L Framework for New Modalities Fierce Pharma
- PAXAFE’s Mark Talens: Supply Chain Teams Must Shift From Firefighters to Orchestrators Pharmaceutical Commerce
- AGCO and Agility Robotics Advance Smart Manufacturing with Humanoid Robot Pilot in Hesston, KS, Facility CropLife
- Where Cold Chain Expertise Gaps Put Advanced Therapies at Risk Pharmaceutical Commerce
- Medtech execs share secrets to building resilient supply chains MedTech Dive